{"schema_version":"1.0","type":"article","title":"PharmaEssentia Acquires FormuRx. Could Making Drugs Inside Cells Be Next?","url":"https://drugnews.com.tw/articles/2026-10-03-pharmaessentia-formurx-rna-lnp-acquisition-2026-en.html","markdown_url":"https://drugnews.com.tw/articles/2026-10-03-pharmaessentia-formurx-rna-lnp-acquisition-2026-en.md","lang":"en","date":"2026-10-03","publish_at":"2026-10-03T20:00:00+08:00","updated_at":"2026-10-03","category":"商業分析系列","topic":"商業分析系列","tags":["PharmaEssentia","FormuRx","RNA","LNP"],"summary":"PharmaEssentia (6446) has acquired FormuRx for approximately NT$168 million. According to company-provided news published by Global Bio & Investment, FormuRx develops delivery technologies for getting RNA into cells. The acquisition brings lipid nanoparticle (LNP) formulations, microfluidic processes, analytical capabilities, equipment and a team.","key_points":[],"facts":[],"sections":[],"references":[],"images":[{"alt":"RNA-development capabilities and team acquired for approximately NT$168 million","url":"https://drugnews.com.tw/assets/articles/pharmaessentia-formurx-rna-lnp-acquisition-2026-en/FIG01_EN_R3.png"},{"alt":"Development schematic of LNP encapsulation, cellular uptake, endosomal release and mRNA translation","url":"https://drugnews.com.tw/assets/articles/pharmaessentia-formurx-rna-lnp-acquisition-2026-en/FIG02_EN_R6D04.png"},{"alt":"Two distinct external preclinical routes for receptor-mRNA delivery, using polymer carriers and LNPs","url":"https://drugnews.com.tw/assets/articles/pharmaessentia-formurx-rna-lnp-acquisition-2026-en/FIG03_EN_R6D04.png"},{"alt":"Development capabilities linking products, RNA formulation, processing, quality and pharmacology assessment","url":"https://drugnews.com.tw/assets/articles/pharmaessentia-formurx-rna-lnp-acquisition-2026-en/FIG04_EN_R6D04.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/pharmaessentia-formurx-rna-lnp-acquisition-2026-en/FIG01_EN_R3.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-10-03）。PharmaEssentia Acquires FormuRx. Could Making Drugs Inside Cells Be Next?。https://drugnews.com.tw/articles/2026-10-03-pharmaessentia-formurx-rna-lnp-acquisition-2026-en.html","disclaimer":"This article is intended for industry research and knowledge sharing only. It does not constitute investment, medical, fundraising, or individual stock advice.","translations":{"zh-Hant":"2026-10-03-pharmaessentia-formurx-rna-lnp-acquisition-2026.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}